OXYGENTA PHARMACEUTICAL
|
OXYGENTA PHARMACEUTICAL Last 5 Year Income Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
| Sales | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | - | - | - | - | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹40 Cr | ₹31 Cr | ₹6,052,481 Cr | ₹52 Cr | ₹14 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-1.53 Cr | ₹-4.64 Cr | ₹454,709 Cr | ₹-6.39 Cr | ₹1.08 Cr |
| Raw Material Consumed | ₹35 Cr | ₹29 Cr | ₹4,267,417 Cr | ₹43 Cr | ₹15 Cr |
| Opening Raw Materials | ₹3.75 Cr | ₹3.97 Cr | ₹425,004 Cr | ₹2.75 Cr | ₹2.78 Cr |
| Purchases Raw Materials | ₹36 Cr | ₹28 Cr | ₹4,239,064 Cr | ₹45 Cr | ₹14 Cr |
| Closing Raw Materials | ₹4.24 Cr | ₹3.75 Cr | ₹396,650 Cr | ₹4.25 Cr | ₹2.75 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - | - |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹4.15 Cr | ₹4.16 Cr | ₹304,090 Cr | ₹2.79 Cr | ₹1.00 Cr |
| Electricity & Power | ₹4.15 Cr | ₹4.16 Cr | ₹304,090 Cr | ₹2.79 Cr | ₹1.00 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹5.99 Cr | ₹5.74 Cr | ₹91,796 Cr | ₹4.08 Cr | ₹2.50 Cr |
| Salaries, Wages & Bonus | ₹5.20 Cr | ₹5.46 Cr | ₹33,439 Cr | ₹3.89 Cr | ₹2.47 Cr |
| Contributions to EPF & Pension Funds | ₹0.35 Cr | ₹0.21 Cr | ₹20,575 Cr | ₹0.18 Cr | - |
| Workmen and Staff Welfare Expenses | ₹0.12 Cr | ₹0.02 Cr | ₹33,485 Cr | ₹0.02 Cr | - |
| Other Employees Cost | ₹0.33 Cr | ₹0.06 Cr | ₹4,297 Cr | - | ₹0.02 Cr |
| Other Manufacturing Expenses | ₹3.28 Cr | ₹2.43 Cr | ₹597,174 Cr | ₹2.88 Cr | ₹1.32 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹0.87 Cr | ₹0.78 Cr | ₹414,066 Cr | ₹0.58 Cr | - |
| Repairs and Maintenance | ₹0.70 Cr | ₹0.10 Cr | ₹47,733 Cr | ₹0.98 Cr | ₹0.43 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹1.72 Cr | ₹1.56 Cr | ₹135,375 Cr | ₹1.32 Cr | ₹0.89 Cr |
| General and Administration Expenses | ₹2.24 Cr | ₹1.72 Cr | ₹188,095 Cr | ₹1.78 Cr | ₹1.12 Cr |
| Rent , Rates & Taxes | ₹0.23 Cr | ₹0.96 Cr | ₹26,632 Cr | ₹0.36 Cr | ₹0.09 Cr |
| Insurance | ₹0.05 Cr | ₹0.05 Cr | ₹11,983 Cr | ₹0.07 Cr | ₹0.06 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹0.41 Cr | ₹0.22 Cr | ₹45,834 Cr | ₹0.22 Cr | ₹0.04 Cr |
| Traveling and conveyance | ₹0.01 Cr | ₹0.05 Cr | ₹482 Cr | ₹0.02 Cr | ₹0.03 Cr |
| Other Administration | ₹1.54 Cr | ₹0.44 Cr | ₹103,164 Cr | ₹1.11 Cr | ₹0.92 Cr |
| Selling and Distribution Expenses | ₹0.11 Cr | ₹0.04 Cr | ₹400 Cr | ₹0.01 Cr | ₹0.05 Cr |
| Advertisement & Sales Promotion | - | - | - | - | - |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | - | - | - | - | - |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹0.11 Cr | ₹0.04 Cr | ₹400 Cr | ₹0.01 Cr | ₹0.05 Cr |
| Miscellaneous Expenses | ₹0.02 Cr | ₹0.01 Cr | ₹1,200 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | - | - | - | - |
| Losson foreign exchange fluctuations | ₹0.01 Cr | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.01 Cr | ₹0.01 Cr | ₹1,200 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹49 Cr | ₹38 Cr | ₹5,904,881 Cr | ₹48 Cr | ₹22 Cr |
| Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹147,599 Cr | ₹3.84 Cr | ₹-7.87 Cr |
| Other Income | ₹0.04 Cr | ₹0.02 Cr | ₹455 Cr | ₹0.09 Cr | ₹0.03 Cr |
| Interest Received | ₹0.02 Cr | ₹0.01 Cr | ₹449 Cr | ₹0.02 Cr | ₹0.02 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹0.03 Cr | ₹0.01 Cr | - | - | - |
| Others | - | - | ₹6.00 Cr | ₹0.07 Cr | ₹0.01 Cr |
| Operating Profit | ₹-9.65 Cr | ₹-7.10 Cr | ₹148,054 Cr | ₹3.93 Cr | ₹-7.83 Cr |
| Interest | ₹1.59 Cr | ₹1.49 Cr | ₹92,494 Cr | ₹1.78 Cr | ₹1.09 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹0.49 Cr | ₹0.59 Cr | ₹86,976 Cr | ₹1.46 Cr | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹0.01 Cr | ₹0.01 Cr | ₹1,018 Cr | ₹0.01 Cr | ₹0.00 Cr |
| Other Interest | ₹1.10 Cr | ₹0.89 Cr | ₹4,500 Cr | ₹0.31 Cr | ₹1.09 Cr |
| PBDT | ₹-11 Cr | ₹-8.59 Cr | ₹55,560 Cr | ₹2.15 Cr | ₹-8.93 Cr |
| Depreciation | ₹2.66 Cr | ₹2.05 Cr | ₹159,132 Cr | ₹1.20 Cr | ₹1.00 Cr |
| Profit Before Taxation & Exceptional Items | ₹-14 Cr | ₹-11 Cr | ₹-103,572 Cr | ₹0.96 Cr | ₹-9.93 Cr |
| Exceptional Income / Expenses | ₹0.04 Cr | ₹-0.73 Cr | ₹54,636 Cr | ₹2.19 Cr | ₹3.99 Cr |
| Profit Before Tax | ₹-14 Cr | ₹-11 Cr | ₹-48,936 Cr | ₹3.14 Cr | ₹-5.94 Cr |
| Provision for Tax | ₹-10 Cr | ₹0.20 Cr | ₹12,110 Cr | ₹0.21 Cr | ₹-0.15 Cr |
| Current Income Tax | - | - | - | - | - |
| Deferred Tax | ₹-10 Cr | ₹0.20 Cr | ₹12,110 Cr | ₹0.21 Cr | ₹-0.15 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹-3.48 Cr | ₹-12 Cr | ₹-61,046 Cr | ₹2.93 Cr | ₹-5.79 Cr |
| Extra items | - | - | - | - | - |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹-60 Cr | ₹-49 Cr | ₹-4,821,990 Cr | ₹-51 Cr | ₹-45 Cr |
| Appropriations | ₹-64 Cr | ₹-60 Cr | ₹-4,883,037 Cr | ₹-48 Cr | ₹-51 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | - | - | - | - | - |
| Equity Dividend % | - | - | - | - | - |
| Earnings Per Share | ₹-1.04 | ₹-8.15 | ₹-0.43 | ₹2.87 | ₹-5.67 |
| Adjusted EPS | ₹-1.04 | ₹-8.15 | ₹-0.43 | ₹2.87 | ₹-5.67 |
Compare Income Statement of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹221.4 Cr | 0.5% | -5.6% | -16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 0.5% |
-5.6% |
-16.7% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses